医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ニュース
添付文書
薬の臨床実感＆助言集
▼×

Reddy’s Laboratories Announces the Launch

Dr. Reddy’s Laboratories Announces the Launch of Vigabatrin Powder for Oral Solution, USP in the U.S. Market

Dr. Reddy’s Laboratories Announces the Launch of Vigabatrin Powder for Oral Solution, USP in the U.S. Market

ヘルスケア製薬　 TimeLine: Reddy's Laboratories Announces the Launch USP in the U.S

2019年08月20日

0

Dr. Reddy’s Laboratories announces the launch of Versavo® (bevacizumab biosimilar) in India

Dr. Reddy’s Laboratories announces the launch of Versavo® (bevacizumab biosimilar) in India

バイオテクノロジーヘルスケア腫瘍学製薬　 TimeLine: bevacizumab biosimilar Reddy's Laboratories Announces the Launch

2019年08月19日

0

Dr. Reddy’s Laboratories announces the launch of Pregabalin Capsules in the U.S. Market

Dr. Reddy’s Laboratories announces the launch of Pregabalin Capsules in the U.S. Market

ヘルスケアヘルス一般製薬　 TimeLine: Reddy's Laboratories Announces the Launch

2019年07月30日

0

Dr. Reddy’s Laboratories Announces the Launch of Ramelteon Tablets, in the U.S. Market

Dr. Reddy’s Laboratories Announces the Launch of Ramelteon Tablets, in the U.S. Market

バイオテクノロジーヘルスケア製薬　 TimeLine: in the U.S Reddy's Laboratories Announces the Launch

2019年07月23日

0

Dr. Reddy’s Laboratories Announces the Launch of Tobramycin Inhalation Solution, USP in the U.S. Market

Dr. Reddy’s Laboratories Announces the Launch of Tobramycin Inhalation Solution, USP in the U.S. Market

バイオテクノロジーヘルスケア製薬　 TimeLine: Reddy's Laboratories Announces the Launch USP in the U.S

2019年06月25日

0

Dr. Reddy’s Laboratories Announces the Launch of Phytonadione Injectable Emulsion USP, 10 mg/ml Single-Dose Ampules in the U.S. Market

Dr. Reddy’s Laboratories Announces the Launch of Phytonadione Injectable Emulsion USP, 10 mg/ml Single-Dose Ampules in the U.S. Market

ヘルスケア製薬　 TimeLine: ml Single-Dose Ampules in the U.S Reddy's Laboratories Announces the Launch

2019年06月22日

0

Dr. Reddy’s Laboratories Announces the Launch of Testosterone Gel, 1.62% (20.25 mg/1.25 g Pump Actuation) in the U.S. Market

Dr. Reddy’s Laboratories Announces the Launch of Testosterone Gel, 1.62% (20.25 mg/1.25 g Pump Actuation) in the U.S. Market

ヘルスケアヘルス一般製薬　 TimeLine: 1.25 g Pump Actuation in the U.S Reddy's Laboratories Announces the Launch

2019年05月06日

0

Dr. Reddy’s Laboratories Announces the Launch of Propofol Injectable Emulsion, USP in the U.S. Market

Dr. Reddy’s Laboratories Announces the Launch of Propofol Injectable Emulsion, USP in the U.S. Market

ヘルスケア製薬　 TimeLine: Reddy's Laboratories Announces the Launch USP in the U.S

2019年01月24日

0

Dr. Reddy’s Laboratories Announces the Launch of Sevelamer Carbonate for Oral Suspension in the U.S. Market

Dr. Reddy’s Laboratories Announces the Launch of Sevelamer Carbonate for Oral Suspension in the U.S. Market

バイオテクノロジーヘルスケア製薬　 TimeLine: for Oral Suspension in the U.S Reddy's Laboratories Announces the Launch

2018年12月27日

0

Dr. Reddy’s Laboratories Announces the Launch of Chlorthalidone Tablets, USP in the U.S. Market

Dr. Reddy’s Laboratories Announces the Launch of Chlorthalidone Tablets, USP in the U.S. Market

ヘルスケアヘルス一般心臓学製薬　 TimeLine: Reddy's Laboratories Announces the Launch USP in the U.S

2018年11月28日

0